Clinical TrialsSearch results
Number of results: 527
Other
- Phase II prospective treatment study for IgG4+MOLPS
- IgG4+MOLPS (IgG4+Multiorgan lymphoproliferative syndrome)
- Department of Hematology and Immunology, Kanazawa Medical University
- 2009-08-10
Other
- Phase II clinical trials of mature B-cell neoplasms in children: A Japanese Cooperative Studies
- mature B-cell non-Hodgkin's lymphoa
- Japanese Pediatric Leukemia/Lymphoma Studu Group(JPLSG)
- 2006-02-05
Other
- Phase II Clinical Trial to test efficacy and safety of relapsed APL (JALSG APL205R study)
- relapsed acute promyelocytic leukemia (APL)
- Japan adult leukemia study group ( JALSG)
- 2005-12-30
Other
- Phase II clinical trial of advanced stage ymphoblastic lymphoma. A Japanese Pediatric Cooperative Study
- Advanced stage lymphoblastic lymphoma of children.
- Japanese Pediatric Leukemia/Lymphoma Study Group(JPLSG)
- 2009-07-26
Other
- Phase I/II trial of chemoradiotherapy concurrent with S-1 and cisplatin in patients with clinical stage II/III esophageal carcinoma (JCOG0604)
- esophageal neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2007-05-08
Other
- Phase I/II Study of Topotecan and Ifosfamide in Pediatric Patients with Relapsed or Refractory Solid Tumors
- Relapse/ refractory pediatric solid tumor
- Group for "making evidence for the drugs which are available in clinical practice in Europe and USA but not available in Japan"
- 2008-02-16
Other
- Phase I/II study of intermittent erlotinib in combination with docetaxel in patients with recurrent non-small cell lung cancer
- Non-small cell lung cancer
- West Japan Oncology Group
- 2009-03-17
Other
- Phase I/II study of hepatic arterial infusion chemotherapy of gemcitabine for unresectable cholangiocarcinoma (JIVROSG-0301)
- Unresectable cholangiocarcinoma
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-07
Other
- Phase I/II study of docetaxel, CDDP and 5-FU therapy in patients with unresectable or recurrent esophageal cancer (JCOG 0807)
- esophageal neoplasm
- Japan Clinical Oncology Group (JCOG)
- 2009-02-27
Other
- Phase I-II clinical trial of irinotecan hydrochloride (CPT-11) for refractory pediatric solid tumors
- Recurrent or progressive pediatric solid tumors (except for malignant lymphoma)
- CPT-PED-05 administrative office
- 2006-01-27